Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 31
- Live patents
- 0
- Shortage listings
- 7
- Countries
- 0
Alert
Drug shortage listings
7| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30) | Current | Limited Availability | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10) | Current | Limited Availability | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10) | Current | Limited Availability | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30) | Current | Limited Availability | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10) | Current | Limited Availability | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10) | Current | Limited Availability | 26 Jul 20231 Oct 2026 |
| Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry | Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30) | Current | Limited Availability | 26 Jul 20231 Oct 2026 |
Catalogue
Drug listings by form and route
3131 active NDC listings: 31 human prescription drug. By marketing category: ANDA 11, UNAPPROVED DRUG OTHER 9, NDA AUTHORIZED GENERIC 6, NDA 5.
| Dosage form | NDCs |
|---|---|
| tablet, extended release | 12 |
| tablet | 8 |
| gel | 5 |
| capsule | 4 |
| elixir | 1 |
| injection | 1 |
| Route | NDCs |
|---|---|
| oral | 25 |
| topical | 5 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| trigen laboratories, llc | 31 |
Catalogue
Marketed products
32Showing 31 of 32.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Estradiol | Estradiol | gel, topical | 13811-090NDA |
| Estradiol | Estradiol | gel, topical | 13811-091NDA |
| Estradiol | Estradiol | gel, topical | 13811-092NDA |
| Estradiol | Estradiol | gel, topical | 13811-093NDA |
| Estradiol | Estradiol | gel, topical | 13811-094NDA |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | tablet, extended release, oral | 13811-701ANDA |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | tablet, extended release, oral | 13811-702ANDA |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | tablet, extended release, oral | 13811-703ANDA |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | tablet, extended release, oral | 13811-704ANDA |
| Lacosamide | Lacosamide | injection, intravenous | 13811-207ANDA |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride | tablet, extended release, oral | 13811-700NDA AUTHORIZED GENERIC |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride | tablet, extended release, oral | 13811-706ANDA |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride | tablet, extended release, oral | 13811-707ANDA |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride | tablet, extended release, oral | 13811-708ANDA |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride | tablet, extended release, oral | 13811-709ANDA |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride | tablet, extended release, oral | 13811-710ANDA |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride | tablet, extended release, oral | 13811-711NDA AUTHORIZED GENERIC |
| Nitrofurantoin | Nitrofurantoin | capsule, oral | 13811-719ANDA |
| Phenobarbital | Phenobarbital | elixir, oral | 13811-299UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-300UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-301UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-302UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-303UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-304UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-305UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-306UNAPPROVED DRUG OTHER |
| Phenobarbital | Phenobarbital | tablet, oral | 13811-307UNAPPROVED DRUG OTHER |
| Tramadol Hydrochloride Extended-Release | tramadol hydrochloride | capsule, oral | 13811-689NDA AUTHORIZED GENERIC |
| Tramadol Hydrochloride Extended-Release | tramadol hydrochloride | capsule, oral | 13811-690NDA AUTHORIZED GENERIC |
| Tramadol Hydrochloride Extended-Release | tramadol hydrochloride | capsule, oral | 13811-691NDA AUTHORIZED GENERIC |
| Venlafaxine Hydrochloride | venlafaxine hydrochloride | tablet, extended release, oral | 13811-712NDA AUTHORIZED GENERIC |
Compare
Other companies listing phenobarbital
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- HARMAN FINOCHEM LIMITED4 sites · 55 NDC
- North American Science Associates, LLC4 sites · 12 NDC
- MEDISCA Inc.2 sites · 305 NDC
- Shandong Xinhua Pharmaceutical Company Limited2 sites · 62 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Proficient Rx LP1 site · 1,729 NDC
- RemedyRepack, Inc1 site · 1,521 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
Enquiry
Common questions
- Is Trigen Laboratories, LLC FDA approved?
- Trigen Laboratories, LLC holds no registered establishment of its own; 32 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Trigen Laboratories, LLC make?
- 32 products are listed under Trigen Laboratories, LLC in the openFDA NDC Directory, most often as tablet, extended release; tablet; gel. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Trigen Laboratories, LLC products in shortage?
- 7 presentations are currently listed in the FDA drug shortage database under Trigen Laboratories, LLC, covering Methylphenidate Hydrochloride Tablet, Extended Release.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.